Scarica l'app Stockscreener
4.29
0.96%
0.04
Unicycive Therapeutics Inc Borsa (UNCY) Ultime notizie
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - MarketScreener
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class Action Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
UNCY Investors with Large Losses Should Contact Robbins LLP - GlobeNewswire
UNCY Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Unicycive Therapeutics, Inc. Class Action - GlobeNewswire Inc.
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of October 14, 2025 Deadline - ACCESS Newswire
Kaplan Fox Alerts Unicycive Therapeutics, Inc. (UNCY) Investors to a Securities Class Action LawsuitDeadline is October 14, 2025 - FinancialContent
Securities Lawsuit Alert: Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
Shareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
Unicycive Therapeutics to Participate in Upcoming Investor Events in September - GlobeNewswire
Kidney Disease Biotech Unicycive Therapeutics Sets Two Major Investor Conference Appearances in September - Stock Titan
Levi & Korsinsky Moves to SueWallSt for Unicycive Therapeutics, Inc. Investors That Lost Money - Stockhouse
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Shareholders who lost money in shares of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Should Contact Wolf Haldenstein Immediately. - PR Newswire
Unicycive Therapeutics Raises $16.3 Million in Stock Sale - MSN
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Shareholders who lost money in shares of Unicycive - GlobeNewswire
Investors SueWallSt as Unicycive Therapeutics, Inc. Faces Securities Fraud Allegations - Nasdaq
Kaplan Fox Alerts Investors of Unicycive Therapeutics, Inc. (UNCY) to a Securities Class Action Deadline on October 14, 2025 - FinancialContent
What earnings revisions data tells us about Unicycive Therapeutics Inc.July 2025 Setups & Weekly Breakout Stock Alerts - Newser
Analyzing drawdowns of Unicycive Therapeutics Inc. with statistical tools2025 Valuation Update & Trade Opportunity Analysis Reports - Newser
Can Unicycive Therapeutics Inc. rally from current levelsJuly 2025 Selloffs & Weekly High Return Stock Forecasts - Newser
Combining machine learning predictions for Unicycive Therapeutics Inc.July 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser
Using Python tools to backtest Unicycive Therapeutics Inc. strategiesJuly 2025 Recap & Accurate Buy Signal Notifications - Newser
Will Unicycive Therapeutics Inc. continue its uptrend2025 Technical Patterns & Smart Investment Allocation Insights - Newser
Using data tools to time your Unicycive Therapeutics Inc. exitWeekly Volume Report & High Yield Equity Trading Tips - Newser
Why Unicycive Therapeutics Inc. is moving todayJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Volume spikes in Unicycive Therapeutics Inc. stock – what they mean2025 Market Sentiment & Consistent Growth Equity Picks - Newser
Heatmap analysis for Unicycive Therapeutics Inc. and competitorsMarket Trend Report & Intraday High Probability Setup Alerts - Newser
Has Unicycive Therapeutics Inc. found a price floorJuly 2025 News Drivers & Daily Technical Forecast Reports - Newser
Shareholders of Unicycive Therapeutics, Inc. (UNCY): Protect Your Rights Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
What the charts say about Unicycive Therapeutics Inc. today2025 Geopolitical Influence & Growth Focused Entry Reports - Newser
SueWallSt With Us: Levi & Korsinsky Notifies Shareholders of Class Action Against Unicycive Therapeutics, Inc - ACCESS Newswire
Unicycive Therapeutics, Inc. (UNCY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 14, 2025 Deadline - ACCESS Newswire
Unicycive Faces Class Action Over FDA Misleading Claims - TipRanks
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Will Unicycive Therapeutics Inc. bounce back from current supportJuly 2025 Macro Moves & Weekly High Return Stock Forecasts - Newser
How hedge fund analytics apply to Unicycive Therapeutics Inc. stockBuy Signal & Breakout Confirmation Trade Signals - Newser
Quantitative breakdown of Unicycive Therapeutics Inc. recent movePortfolio Return Summary & Detailed Earnings Play Alerts - Newser
Unicycive Therapeutics faces securities class action lawsuit over public statements - Investing.com India
Levi & Korsinsky Urges Unicycive Therapeutics, Inc. (UNCY) Shareholders to Act Before Lead Plaintiff Deadline October 14, 2025 - ACCESS Newswire
October 14, 2025 Deadline: Join Class Action Lawsuit Against Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky - ACCESS Newswire
Unicycive Faces Securities Lawsuit Over Drug Claims - TipRanks
Unicycive Therapeutics says co became aware of securities class action lawsuit - MarketScreener
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
0.67%
9.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):